Calendrier des promotions Indivior PLC
Calendrier avancé
Graphique simple
À propos de l'entreprise Indivior PLC
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet. The company operates in approximately 40 countries worldwide. It has collaboration agreement with Addex Therapeutics Ltd. plus de détailsIPO date | 2014-12-29 |
---|---|
ISIN | GB00BN4HT335 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 12.24 |
Дивиденд ао | 0.475 |
Сайт | https://www.indivior.com |
Цена ао | 8.71 |
Changement de prix par jour: | +0.487% (12.32) |
---|---|
Changement de prix par semaine: | +6.17% (11.66) |
Changement de prix par mois: | +9.27% (11.33) |
Changement de prix sur 3 mois: | +23.31% (10.04) |
Changement de prix sur six mois: | -18.93% (15.27) |
Changement de prix par an: | -18.93% (15.27) |
Evolution du prix sur 3 ans: | +1 792.97% (0.654) |
Evolution du prix sur 5 ans: | +12 959.07% (0.0948) |
Evolution des prix sur 10 ans: | 0% (12.38) |
Evolution des prix depuis le début de l'année: | +18.41% (10.455) |
|
Sous-estimation
|
Efficacité
|
|||||||||||||||||||||||||||||||||||||
Dividendes
|
Devoir
|
Impulsion de croissance
|
Établissements | Volume | Partager, % |
---|---|---|
Two Seas Capital LP | 13670312 | 9.96 |
Scopia Capital Management LP | 8311367 | 6.06 |
Vanguard Group Inc | 5846354 | 4.26 |
Goldman Sachs Group Inc | 5683038 | 4.14 |
FMR, LLC | 5498087 | 4.01 |
Artemis Investment Management LLP | 3127399 | 2.28 |
Bank of America Corporation | 2701855 | 1.97 |
Polar Capital Holdings PLC | 2621150 | 1.91 |
Acadian Asset Management. LLC | 2281179 | 1.66 |
Liontrust Investment Partners LLP | 1995889 | 1.45 |
ETF | Partager, % | Rentabilité pour l'année, % | Dividendes, % |
---|---|---|---|
Schwab International Small-Cap Equity ETF | 0.05297 | 10.07 | 3.20638 |
![]() |
0.05 | 9.39 | 3.09932 |
Dimensional International Small Cap ETF | 0.03912 | 5.69 | 3.34747 |
Avantis International Small Cap Value ETF | 0.03727 | 14.36 | 4.23496 |
Avantis International Equity ETF | 0.01813 | 6.46 | 3.80856 |
Invesco FTSE RAFI Developed Markets ex-U.S. Small-Mid ETF | 0.01806 | 2.77 | 3.5165 |
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund | 0.01219 | 5.17 | 3.85434 |
SPDR Portfolio Europe ETF | 0.00943 | 8.94 | 3.66537 |
Dimensional World ex U.S. Core Equity 2 ETF | 0.00881 | 13.06 | 3.62488 |
Dimensional International Core Equity 2 ETF | 0.00651 | 6.52 | 3.69996 |
![]() |
0.00638 | 5.29 | 3.28401 |
Dimensional International Core Equity Market ETF | 0.00363 | 13.09 | 3.48343 |
SPDR Portfolio MSCI Global Stock Market ETF | 0.00137 | 17.99 | 2.19607 |
Superviseur | Titre d'emploi | Paiement | Année de naissance |
---|---|---|---|
Mr. Mark Crossley | CEO & Executive Director | 2.34M | |
Mr. Ryan Preblick | CFO & Executive Director | 1.14M | |
Dr. Christian Heidbreder | Chief Scientific Officer | N/A | |
Mr. Jason Thompson | Vice President of Investor Relations | N/A | |
Ms. Cynthia Cetani | Chief Integrity & Compliance Officer | N/A | |
Mr. Jeffrey W. Burris | Chief Legal Officer | N/A | 1972 (53 année) |
Mr. Jon Fogle | Chief Human Resources Officer | N/A | |
Mr. Richard Simkin | Chief Commercial Officer | N/A | |
Mr. Hillel West | Chief Manufacturing & Supply Officer | N/A | |
Mr. Vishal Kalia | SVP of US Treatment Access, Support Programs & Business Insights and Chief Impact & Strategy Officer | N/A |
Adresse: United States, North Chesterfield. VA, 10710 Midlothian Turnpike - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.indivior.com
Site web: https://www.indivior.com